Atlas Trials

Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions

Clinical trial NCT02863133 · UNKNOWN

Trial details

NCT number
NCT02863133
Sponsor
Antia Therapeutics AG
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Arterial Embolization
Start date
2016-10-01
Primary completion
2017-10-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.